Dermira, Inc.(Dermira) is a development-stage company focuses on developing and commercializing new therapies in dermatology. The company operates in the US and Canada. The company’s product pipelines includes late-stage products, such as Cimzia, Glycopyrronium Tosylate (formerly DRM04) and Olumacostat Glasaretil (formerly DRM01). Dermira’s Cimzia is a tumor necrosis factor (TNF) inhibitor that specifically targets the overproduction of the human protein TNF. Cimzia is developed for the treatment of adults for reducing signs and symptoms of Crohn’s disease and maintaining clinical response in adult patients. The company develops this product with the collaboration partner of UCB. Glycopyrronium Tosylate (formerly DRM04) is a topical, small-molecule anticholinergic product for the treatment of hyperhidrosis. Anticholinergics are a class of pharmaceutical products that exert their effect by blocking the action of acetylcholine, a molecule that transmits signals within the nervous system that are responsible for a range of bodily functions, including the activation of sweat glands. Olumacostat Glasaretil (formerly DRM01) is a small-molecule sebum inhibitor for the treatment of acne. Sebum is an oily substance made up of lipids produced by glands in the skin called sebaceous glands, and excessive sebum production is an important aspect of acne. Olumacostat Glasaretil is in the third phase of research and development.
Scope of the Report
-- About the Company - Historical Details, Current Ownership Structure and basic overview of Dermira, Inc. in terms of revenue, net income, and operating income.
-- Financials - Details about Dermira, Inc. listing status, annual financial reports (for the past 5 years), key financial highlights and region wise and category wise breakdown of their net revenue.
-- Products / Services - Listing of the company’s entire portfolio along with description of individual products / services providing a clear picture of their target audience.
-- Company SWOT Analysis - Outlines Dermira, Inc.’s strengths, weaknesses, and opportunities and threats facing the company.
-- Recent Developments - Showcases Dermira, Inc.’s recent developments including mergers, acquisitions, partnerships, collaborations, new product launches, investment and divestment plans.
-- Strategic Evaluation - Provides an overview of Dermira, Inc.’s corporate goals and strategic initiatives and evaluates their outcomes along with outlining any persisting legal issues and outlook of our in-house analyst panel on the particular company.
-- Technology Landscape - Details how the company allocates its IT budget across the core areas of its business, CIO/CTO Profile, Key IT Initiatives and Deals undertaken buy the company at present along with outlook.
Key Questions Answered
-- What domain does Dermira, Inc. operate and what are key points about it?
-- What is the product / service portfolio of Dermira, Inc.?
-- How has Dermira, Inc. performed financially from the 2013?
-- How does Dermira, Inc. rank among its peers in terms of revenue and market share?
-- What are Dermira, Inc. strengths and weaknesses and what opportunities and threats does it face?
-- What are Dermira, Inc.’s main growth strategies and how successful has the company been at implementing them?
-- What is the in-house technical capability of Dermira, Inc.? Where does it procure / outsource it?
Reasons to buy
-- Report delivered in easily accessible PPT format which can be used to gain insights quickly and further prepare presentations of your own
-- Lean pricing structure ultimately giving you vast access to the unlimited knowledge repository of the company profiles at very competitive cost
-- 12 hour delivery time fulfilling your urgent requests as per your requirement
-- On-demand customization options that can completely cater to your needs by focusing the report onto given specifics
1. About the Company
1.1 History and Basic Facts
1.2 Ownership Structure and Key Executives
1.3 Head Office
1.4 Other Locations & Subsidiaries
1.5 List of Competitors
1.6 Employee Count & Distribution
2.1 Company Type (Listed / Unlisted)
2.2 Annual Statements
2.3 Key Financial Highlights
2.4 Region-wise Breakdown
3. Product / Services
4. SWOT Analysis
4.1 SWOT Overview
5. Recent Developments
5.1 Mergers & Acquisitions
5.2 Partnerships, Collaborations & Joint Ventures
5.3 New Product Launches
5.4 Business Expansion / Divestment
6. Strategic Evaluation
6.1 Corporate Strategy
6.2 Legal Issues
6.3 Analyst Outlook
7. Technology Landscape
-- 7.1.1 Industry Snapshot
-- 7.1.2 IT Spend
-- 7.1.3 Key Information Technology Trends
-- 7.2.1 IT Overview
-- 7.2.2 Key IT Technologies
-- 7.2.3 Recent IT Initiatives
-- 7.2.4 IT Outsourcing Engagements
-- 7.2.5 Key IT Management
-- 7.2.6 CIO/CTO Profile
-- About Us
-- Contact Us
Fig.1: Company Snapshot
Fig.2: Locations Listing on Map
Table.1: Ownership Structure
Table.2: List of Competitors
Table.3: Annual Statements
Table.4: Key Financial Highlights
Table.5: Region-wise Breakdown
Table.6: Product/Services Overview
Table.7: Mergers & Acquisitions
Table.8: Partnerships, Collaborations & Joint Ventures
Table.9: New Product Launches
Table.10: Business Expansion / Divestment
Table 11: IT Budgets
Table 12: Key IT Management (CIO / CTO)
Table 13: IT Deals undertaken in the past years